.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Island Therapeutics has shown a notable presence in the British Columbia market, particularly in the Topical category. As of December 2025, the brand held the 6th position, indicating a strong foothold in this niche. However, the absence of rankings for January through March 2026 suggests a potential decline in their market presence or a strategic shift away from this category. This lack of ranking in the subsequent months could be a cause for concern, as it might imply that Island Therapeutics was not among the top 30 brands in the Topical category during this period, highlighting a possible need for reassessment or reinvigoration of their strategies in this market segment.
In terms of sales, Island Therapeutics recorded $13,278 in December 2025, which sets a benchmark for their performance in the Topical category. However, the absence of subsequent sales data for the first quarter of 2026 leaves room for speculation about their current market dynamics. This data gap could suggest either a decline or a strategic pause, which may impact their market share in British Columbia. Understanding these trends is crucial for stakeholders looking to gauge the brand's future trajectory and potential areas of growth or reinvention.
Competitive Landscape
In the competitive landscape of the topical cannabis market in British Columbia, Island Therapeutics experienced notable fluctuations in its ranking. As of December 2025, Island Therapeutics was ranked 6th, but it did not appear in the top 20 for the subsequent months, indicating a potential decline in market presence or sales performance. In contrast, Wildflower Canada maintained a strong position, ranking 4th in December 2025 and improving to 3rd in January 2026, before stabilizing at 5th in February and March 2026. This consistent performance by Wildflower Canada suggests a robust market strategy and customer loyalty, which may pose a challenge for Island Therapeutics. Meanwhile, NaturalREM was ranked 7th in December 2025 but did not appear in the top 20 in the following months, similar to Island Therapeutics. These dynamics highlight the competitive pressures faced by Island Therapeutics and underscore the importance of strategic adjustments to regain and sustain market visibility and sales momentum.
Notable Products
In March 2026, the top-performing product from Island Therapeutics was the CBD Relaxation Bath Salts (300mg CBD), maintaining its consistent number one rank for four consecutive months with a sales figure of 169 units. The CBD Relaxation Bath Bomb (200mg CBD, 125g) climbed back to the second position after dropping to fifth in February, indicating a resurgence in popularity. The CBD Intimate Bath Bomb (200mg CBD) held steady at the third position, maintaining its rank from February. The CBD Rejuvenation Bath Bomb (200mg CBD) showed improvement, rising from fourth to a shared third rank. Notably, the CBD Transdermal Patch 6-Pack (120mg CBD) was not ranked in March, indicating a possible decline in sales or availability.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
